HeartBeam, Inc.
HeartBeam, Inc. (BEAT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BEAT · as of Jun 8, 2026
Key Statistics
Explore HeartBeam, Inc. Data
beat stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 13 · Buy rate: 69.2%
The BEAT analyst consensus is Buy, based on ratings from 13 Wall Street analysts over the past 3 months. The average 12-month price target is $5.50, representing +579.01% upside from the current price of $0.81.
Competitors & Peers
beat competitorsBEAT
CRVO
EQ
HOWL
INKT
IOBTStock Performance
Full HistoryAbout HeartBeam, Inc.
HeartBeam, Inc. is a medical technology firm specializing in remote cardiac care. The company provides telemedicine solutions designed to diagnose and monitor heart conditions outside of traditional h…
what is heartbeam, inc. · beat stock overview · heartbeam, inc. company profile · who is heartbeam, inc. ceo · beat NASDAQ · heartbeam, inc. headquarters · heartbeam, inc. business segments
About Stock Overview & Key Data
HeartBeam, Inc. (BEAT) is a Healthcare company in the Medical - Healthcare Information Services industry, listed on NASDAQ since Nov 11, 2021. As of the latest trading session, BEAT stock price is $0.81, with a market capitalization of $27.9M. The stock has returned -49.06% over the past 12 months and -66.25% year-to-date.
According to 13 Wall Street analysts, the consensus rating for HeartBeam, Inc. stock is Buy, with an average 12-month price target of $5.50. In fiscal year 2025, HeartBeam, Inc. reported revenue of — and net income of -$21.0M. For detailed data — including HeartBeam, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, HeartBeam, Inc. (BEAT) stock price is $0.81. The stock is traded on NASDAQ under the ticker symbol BEAT. The 52-week range is $0.54 – $4.00.